Minae An retweeted
Spotlighting the macrophage cells in our blood and tissue, their role in diseases, and targeted interventions
cell.com/immunity/fulltext/S… @ImmunityCP
Minae An retweeted
With interest in PD-1xVEGF across cancers we add some data from Ram and Pembro. @CIR_AACR @JeeyunM @AnMinae @arnavmehta3
Distinct spatially resolved TME trajectories define benefit from ramucirumab + pembro in refractory PD-L1+ gastric cancer aacrjournals.org/cancerimmun…
Minae An retweeted
jitc.bmj.com/content/13/9/e0…
Nice collaboration with @KoheiShitara @AnMinae Takeshi Kuwata on dynamic change of claudin 18.2 during chemo plus pem tx.
Thank you for listening to my talk about spatial transcriptome research in gastric cancer. It was nice to meet everyone I spoke with at AACR-JCA conference. This research journey was thanks to the mentorship of @JeeyunM
5
210
Minae An retweeted
Adding some spatial omics to HER2+ gastric cancer.
Determinants of Response to Sequential Pembrolizumab with Trastuzumab Plus Platinum/5FU in HER2-positive Gastric Cancer: A Phase II Trial
aacrjournals.org/clincancerr…
@JeeyunM @AnMinae @arnavmehta3 @CCR_AACR
Minae An retweeted
In today's Nature: A ‘Wikipedia for cells’ nature.com/articles/d41586-0…
nature.com/immersive/d42859-…
Minae An retweeted
Need to design your next Xenium/CosMx/Merfish experiment? Spapros, now out @naturemethods, allows for probe set selection for target spatial tx. Led by @KuemmerleLouis, it optimizes both cell type ID & within-cell type variation. nature.com/articles/s41592-0… github.com/theislab/spapros
Minae An retweeted
Great to have another option for patients. @KoheiShitara @mdmanishshah @ILSONDavid @FlorianLordick @sara_lonardi1 and many others.
FDA Approves Zolbetuximab Plus Chemo for CLDN18.2+ Gastric or GEJ Adenocarcinoma onclive.com/view/fda-approve… via @onclive
I’m deeply honored to receive this award (future leader award) for my postdoctoral work.
aacrjournals.org/cancerdisco…
aacrjournals.org/cancerdisco…
I am also incredibly grateful to my mentor @JeeyunM and my colleagues who guided and worked alongside me.
Minae An retweeted
🚨Update from #ESMO24 Upper GI cancer data 🚨
Dr @LizzySmyth1 & Dr @KlempnerSam joined us at ESMO to share their insights into new #UpperGI cancer data & the potential impact on clinical practice.
📺 Watch their video update
Supported by Bayer #MedEd #oncology #OncTwitter
Minae An retweeted
Presented at #ESMO24:
The addition of pembrolizumab to trastuzumab and chemotherapy in patients with gastric cancer improved both progression-free and overall survival as compared with trastuzumab and chemotherapy alone. Full KEYNOTE-811 trial results: nej.md/47BTmYp
It was great to be the part of the research partnership day. #SamsungMedicalCenter
4
105
Minae An retweeted
Deepening our international gastric cancer collaborations with @JeeyunM and her team. Pleasure to host talented post docs Dr. Minae An and Dr. Jaeyun Jung at @MGHCancerCenter @arnavmehta3 @AnMinae
See their recent preprint here medrxiv.org/content/10.1101/…





















